Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

Details 詳細情報について

• CRID

  1363951796046471296

• DOI

  10.1093/annonc/mdv012

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419314681?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419314681?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/26/4/724/16699521/mdv012.pdf

• Data Source

  • Crossref